Tyler Campbell’s own career was cut short by neurological disease
" />

Please login to the form below

Not currently logged in
Email:
Password:

Biogen Idec enlists son of NFL star for MS campaign

Tyler Campbell’s own career was cut short by neurological disease
Tyler Campbell Biogen MS campaign

Biogen Idec has signed up former NFL player Earl Campbell and his son Tyler to support a campaign to encourage people affected by multiple sclerosis (MS) to share their stories.

Earl Campbell was a successful American football player for Houston Oilers in the 1970s and 1980s and Tyler had hoped to follow his father's success in the game.
However, after a promising college career Tyler Campbell was diagnosed with relapsing-remitting MS (RRMS) and had to give up his sports dream.

Campbell has since dedicated his life to raise awareness of RRMS and supporting people with the condition and Biogen hopes that his story will encourage others living with RRMS to share their own stories.

As part of the campaign Biogen has launched the website MSInspiration.com where people living with RRMS, or their friends or loved ones, can submit a short essay about how living with or knowing someone who lives the condition has shaped and inspired them.

Three winning entries will be picked to win a prize of tickets to a sporting event with Campbell or Chris Wright, a professional basketball player who also has RRMS.

The website also includes further information on the stories of Campbell and Wright, as well as dancer-turned-director Jessica Pelle and campaigner Marci Viland.

"I was devastated by my diagnosis, but I soon realised that everything happens for a reason,” said Tyler. “While it may be hard to believe, relapsing MS has made my life richer and more meaningful, and has strengthened my bond with my family.”

According to Biogen Idec there are around 400,000 people in the US living with MS, of which 85% are initially diagnosed with RRMS, which is characterised by acute attacks of symptoms such as numbness in the limbs, paralysis or loss of vision.

Biogen Idec has long been in leader in MS therapies, with major products including Tysabri (natalizumab) and the oral medicine Tecfidera (dimethyl fumarate).

29th January 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics